SkinHealth Systems (SKIN) vs Neuronetics (STIM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SkinHealth Systems (SKIN) has outperformed Neuronetics (STIM) over the past year, gaining 791.7% versus a loss of 4.6%. Over five years, SKIN leads with a -57.1% price change compared with -69.7% for STIM. Neuronetics is the larger company by market cap ($120.6 million vs $76.7 million), about 1.6 times the size.
SkinHealth Systems converts more of its revenue into profit, with a net margin of -3.2% versus -26.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SKIN | STIM |
|---|---|---|
| Share price | $11.77 | $1.25 |
| Market cap | $76.68M | $120.60M |
| 1-day change | -3.13% | +0.81% |
| YTD return | +746.76% | -9.42% |
| 1-year return | +791.67% | -4.58% |
| 5-year return | -57.11% | -69.66% |
| Forward P/E | 2.63 | — |
| EPS (TTM) | $-2.98 | $-0.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $300.79M | $149.16M |
| Revenue growth (YoY) | -10.02% | +99.17% |
| Net income (latest FY) | $-9.52M | $-39.00M |
| Gross margin | 65.28% | 48.48% |
| Operating margin | -6.92% | -21.08% |
| Net margin | -3.16% | -26.15% |
| 52-week high | $33.00 | $3.44 |
| 52-week low | $9.68 | $0.80 |
| Distance from 52-week high | -64.33% | -63.66% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +24.64% | +380.00% |
| Average volume | 43.46K | 1.76M |
| Shares outstanding | 6.51M | 96.48M |
| Employees | 613 | 658 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SKIN has outperformed STIM by 796.2 percentage points over the past year.
- SkinHealth Systems is more profitable, keeping -3.2 cents of every revenue dollar as net income versus -26.1 cents for Neuronetics.
- Neuronetics grew revenue faster in its latest fiscal year (+99.17% vs -10.02%).
About SkinHealth Systems
SKIN stock →SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.
Health Care · Medical/Dental Instruments · 613 employees
About Neuronetics
STIM stock →Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 658 employees
SKIN vs STIM FAQ
Which is bigger, SkinHealth Systems or Neuronetics?
Neuronetics (STIM) is larger, with a market capitalization of $120.60M compared with $76.68M for SkinHealth Systems (SKIN).
Which stock has performed better over the past year, SKIN or STIM?
SKIN returned +791.67% over the past 12 months, compared with -4.58% for STIM (price return, excluding dividends). Past performance does not predict future results.
Are SkinHealth Systems and Neuronetics in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.